David Guzo

Array ( [id] => 307581 [patent_doc_number] => 07531647 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-12 [patent_title] => 'Lentiviral vectors for site-specific gene insertion' [patent_app_type] => utility [patent_app_number] => 12/107015 [patent_app_country] => US [patent_app_date] => 2008-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11275 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/531/07531647.pdf [firstpage_image] =>[orig_patent_app_number] => 12107015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4797861 [patent_doc_number] => 20080009447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of SOCS sequence in the animal' [patent_app_type] => utility [patent_app_number] => 11/825986 [patent_app_country] => US [patent_app_date] => 2007-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7922 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20080009447.pdf [firstpage_image] =>[orig_patent_app_number] => 11825986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4704582 [patent_doc_number] => 20080064106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'Lentiviral LTR-deleted vector' [patent_app_type] => utility [patent_app_number] => 11/726679 [patent_app_country] => US [patent_app_date] => 2007-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9222 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064106.pdf [firstpage_image] =>[orig_patent_app_number] => 11726679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5253317 [patent_doc_number] => 20070134773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'METHOD FOR PRODUCING L-GLUTAMIC ACID BY FERMENTATION ACCOMPANIED BY PRECIPITATION' [patent_app_type] => utility [patent_app_number] => 11/668079 [patent_app_country] => US [patent_app_date] => 2007-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10685 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134773.pdf [firstpage_image] =>[orig_patent_app_number] => 11668079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4971306 [patent_doc_number] => 20070111308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Use of Stem Cells Derived From Dermal Skin' [patent_app_type] => utility [patent_app_number] => 11/610021 [patent_app_country] => US [patent_app_date] => 2006-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1678 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20070111308.pdf [firstpage_image] =>[orig_patent_app_number] => 11610021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 586429 [patent_doc_number] => 07439066 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-21 [patent_title] => 'Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV)' [patent_app_type] => utility [patent_app_number] => 11/593963 [patent_app_country] => US [patent_app_date] => 2006-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 21767 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/439/07439066.pdf [firstpage_image] =>[orig_patent_app_number] => 11593963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5236010 [patent_doc_number] => 20070128166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Adenoviral vectors having a protein IX deletion' [patent_app_type] => utility [patent_app_number] => 11/585742 [patent_app_country] => US [patent_app_date] => 2006-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 16177 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128166.pdf [firstpage_image] =>[orig_patent_app_number] => 11585742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 602284 [patent_doc_number] => 07432047 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-07 [patent_title] => 'Method for selective inactivation of viral replication' [patent_app_type] => utility [patent_app_number] => 11/543710 [patent_app_country] => US [patent_app_date] => 2006-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 50654 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/432/07432047.pdf [firstpage_image] =>[orig_patent_app_number] => 11543710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5148226 [patent_doc_number] => 20070048285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Self-inactivating retroviral vector' [patent_app_type] => utility [patent_app_number] => 11/509488 [patent_app_country] => US [patent_app_date] => 2006-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9885 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20070048285.pdf [firstpage_image] =>[orig_patent_app_number] => 11509488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4994672 [patent_doc_number] => 20070010017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'LENTIVIRAL PACKAGING CONSTRUCTS' [patent_app_type] => utility [patent_app_number] => 11/428118 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9168 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010017.pdf [firstpage_image] =>[orig_patent_app_number] => 11428118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4994141 [patent_doc_number] => 20070009486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Adenoviral vectors having a protein IX deletion' [patent_app_type] => utility [patent_app_number] => 11/453625 [patent_app_country] => US [patent_app_date] => 2006-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 16152 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20070009486.pdf [firstpage_image] =>[orig_patent_app_number] => 11453625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5625378 [patent_doc_number] => 20060263883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Recombinant herpes viruses for preparing recombinant adeno-associated viruses' [patent_app_type] => utility [patent_app_number] => 11/415024 [patent_app_country] => US [patent_app_date] => 2006-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8699 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263883.pdf [firstpage_image] =>[orig_patent_app_number] => 11415024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5858696 [patent_doc_number] => 20060228700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Novel retrovirus associated with myelodysplastic syndromes and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/385978 [patent_app_country] => US [patent_app_date] => 2006-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22668 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20060228700.pdf [firstpage_image] =>[orig_patent_app_number] => 11385978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632238 [patent_doc_number] => 20060148708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'C5a receptor' [patent_app_type] => utility [patent_app_number] => 11/367538 [patent_app_country] => US [patent_app_date] => 2006-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12659 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148708.pdf [firstpage_image] =>[orig_patent_app_number] => 11367538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5672579 [patent_doc_number] => 20060177934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Lentiviral LTR-deleted vector' [patent_app_type] => utility [patent_app_number] => 11/367657 [patent_app_country] => US [patent_app_date] => 2006-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9636 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20060177934.pdf [firstpage_image] =>[orig_patent_app_number] => 11367657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5785463 [patent_doc_number] => 20060205079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Amplifiable adeno-associated virus (AAV) packaging cassettes for the production of recombinant AAV vectors' [patent_app_type] => utility [patent_app_number] => 11/341249 [patent_app_country] => US [patent_app_date] => 2006-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18073 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205079.pdf [firstpage_image] =>[orig_patent_app_number] => 11341249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5655175 [patent_doc_number] => 20060140910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Recombinant adenoviral vectors and methods of use' [patent_app_type] => utility [patent_app_number] => 11/319873 [patent_app_country] => US [patent_app_date] => 2005-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16077 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20060140910.pdf [firstpage_image] =>[orig_patent_app_number] => 11319873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5865057 [patent_doc_number] => 20060099187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Adenoviral vectors having a protein IX deletion' [patent_app_type] => utility [patent_app_number] => 11/315777 [patent_app_country] => US [patent_app_date] => 2005-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 16079 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20060099187.pdf [firstpage_image] =>[orig_patent_app_number] => 11315777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5682977 [patent_doc_number] => 20060199247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Method for identifying modulators gene expression' [patent_app_type] => utility [patent_app_number] => 11/315034 [patent_app_country] => US [patent_app_date] => 2005-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9989 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20060199247.pdf [firstpage_image] =>[orig_patent_app_number] => 11315034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5850568 [patent_doc_number] => 20060233759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Adenoviral vectors having a protein IX deletion' [patent_app_type] => utility [patent_app_number] => 11/304280 [patent_app_country] => US [patent_app_date] => 2005-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 16066 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20060233759.pdf [firstpage_image] =>[orig_patent_app_number] => 11304280 [rel_patent_id] =>[rel_patent_doc_number] =>)